This book is an edited collection of papers by leading experts on the population genetics and evolutionary biology of malaria, a disease which results in three million deaths
| Preface | | ix | |
| Contributors | | xi | |
| 1. Introduction | |
| |
| 1. The Haldane Hypothesis |
| | 2 | (3) |
| 2. Glucose-6-Phosphate Dehydrogenase Deficiency and Malarial Resistance |
| | 5 | (1) |
| 3. Phagocytosis of Ring Forms |
| | 6 | (1) |
| 4. Evolutionary Considerations: Malaria`s Eve Hypothesis |
| | 6 | (2) |
| | 8 | (2) |
| | 10 | (6) |
| 2. J.B.S. Haldane (1892-1964) | |
| |
| | 16 | (1) |
| | 17 | (1) |
| | 17 | (1) |
| | 18 | (1) |
| | 19 | (1) |
| | 19 | (2) |
| | 21 | (1) |
| | 21 | (1) |
| | 22 | (3) |
| 3. Removal of Early Parasite Forms from Circulation as a Mechanism of Resistance Against Malaria in Widespread Red Blood Cell Mutations | |
| Paolo Arese, Kodjo Ayi, Aleksei Skorokhod and Franco Turrini |
| |
| | 25 | (2) |
| 2. Malaria is Responsible for High Frequency and Regional Distribution of Major Protective RBC Mutations: Geographical Evidence |
| | 27 | (2) |
| 3. Epidemiological Evidence: Degree of Protection Afforded by RBC Mutations |
| | 29 | (3) |
| 3.1. Hemoglobin AS (Sickle-Cell Trait) |
| | 29 | (1) |
| | 29 | (1) |
| | 30 | (1) |
| | 30 | (1) |
| 3.5. Glucose-6-Phosphate Dehydrogenase |
| | 31 | (1) |
| 3.6. Southeast Asian Ovalocytosis |
| | 32 | (1) |
| 4. A Critical Assessment of the Current Mechanism of Protection by Widespread RBC Mutations |
| | 32 | (7) |
| | 36 | (1) |
| | 36 | (1) |
| | 37 | (1) |
| 4.4. Glucose-6-Phosphate Dehydrogenase Deficiency |
| | 38 | (1) |
| 5. Modifications in the RBC Membrane Elicited by the Developing |
| |
| Parasite Induce Phagocytosis |
| | 39 | (1) |
| 5.1. Similarity of Ring Phagocytosis to Phagocytosis |
| |
| of Normal Senescent or Oxidatively Stressed RBCs |
| | 39 | (2) |
| 6. Enhanced Phagocytosis of Ring Forms as a Model of Protection for Widespread RBC Mutations |
| | 41 | (7) |
| 6.1. Membrane Binding of Hemichromes, Autologous IgG, Complement C3c Fragment; Aggregated Band 3 and Phagocytosis in Nonparasitized and Ring-Parasitized Normal and Mutant RBCs |
| | 41 | (2) |
| 6.2. Why are Rings Developing in Beta-Thalassemia, Sickle-Cell Trait, HbH, and G6PD-deficient RBCs Phagocytosed More Intensely than Rings Developing in Normal RBCs? |
| | 43 | (2) |
| 6.3. What is the Evidence that Ring-Parasitized Mutant RBCs are Also Preferentially Removed In Vivo? |
| | 45 | (1) |
| 6.4. Why is Preferential Removal of Ring-Forms Advantageous to the Host? |
| | 46 | (1) |
| 6.5. Why are Rings Developing in Alpha-Thalassemia Very Similar to Controls? |
| | 46 | (2) |
| | 48 | (2) |
| | 50 | (6) |
| 4. Clinical, Epidemiological, and Genetic Investigations on Thalassemia and Malaria in Italy | |
| Stefano Canali and Gilberto Corbellini |
| |
| 1. The Evolution of the Knowledge of Thalassemia Genetics: The Italian Contribution |
| | 56 | (2) |
| 2. Early Observations on the Association between Malaria and Thalassemia |
| | 58 | (5) |
| 3. Collaboration of Silvestroni and Bianco with Montalenti: At Work on Haldane`s Hypothesis |
| | 63 | (5) |
| 4. Research of Carcassi et al. |
| | 68 | (1) |
| 5. Studies on Microcythemia Genetics in Italy Funded by the Rockefeller Foundation |
| | 69 | (5) |
| 6. The Results of Siniscalco`s Genetic Studies on the Distribution of Thalassemia, G-6-PD Deficit, and of Malaria |
| | 74 | (1) |
| 7. The Malaria Hypothesis and the Consequences of Eradicating the Plasmodia and of Thalassemia Prevention |
| | 75 | (1) |
| | 76 | (1) |
| | 77 | (1) |
| | 77 | (4) |
| 5. Resistance to Antimalarial Drugs: Parasite and Host Genetic Factors | |
| Rajeev K. Mehlotra and Peter A. Zimmerman |
| |
| | 81 | (1) |
| | 82 | (1) |
| 3. Antimalarial Chemotherapy and Chemoprophylaxis |
| | 83 | (3) |
| 3.1. Drugs Available for Treatment of Malaria |
| | 83 | (3) |
| 4. Antimalarial Drug Resistance |
| | 86 | (10) |
| 4.1. Current Status of Drug-Resistant Malaria |
| | 86 | (3) |
| 4.2. Parasite Genetic Polymorphism As a Basis for Antimalarial Resistance |
| | 89 | (1) |
| 4.3. Genes Associated with Chloroquine Resistance in P. falciparum |
| | 90 | (3) |
| 4.4. Mechanism of Resistance to Antifolate Combination Drugs in P. falciparum |
| | 93 | (1) |
| 4.5. Mechanism of Atovaquone Resistance in P. falciparum |
| | 94 | (1) |
| 4.6. Mechanisms of Drug Resistance in P. vivax |
| | 95 | (1) |
| | 96 | (13) |
| 5.1. Cytochrome P450 Enzyme Superfamily |
| | 96 | (2) |
| 5.2. Uridine Diphosphate Glucuronosyltransferase Enzyme Superfamily |
| | 98 | (2) |
| 5.3. Antimalarial Drug Metabolism |
| | 100 | (4) |
| 5.4. Antimalarial Drug Levels and Treatment Outcome |
| | 104 | (5) |
| | 109 | (1) |
| | 110 | (1) |
| | 110 | (15) |
| 6. Evolutionary Origins of Human Malaria Parasites | |
| Stephen M. Rich and Francisco J. Ayala |
| |
| 1. The Phylum Apicomplexa |
| | 125 | (2) |
| | 127 | (5) |
| 3. Transfers Between Human and Monkey Hosts |
| | 132 | (3) |
| 4. Population Structure of Plasmodium falciparum |
| | 135 | (2) |
| 5. Malaria`s Eve Hypothesis |
| | 137 | (3) |
| 6. Malaria`s Eve Counterarguments |
| | 140 | (2) |
| | 142 | (1) |
| | 143 | (4) |
| 7. Vector Genetics in Malaria Control | |
| |
| | 147 | (1) |
| | 147 | (2) |
| 2. The Anopheles culicifacies Complex |
| | 149 | (7) |
| | 154 | (2) |
| 3. Application in Malaria Control |
| | 156 | (8) |
| | 157 | (1) |
| 3.2. Insecticide Resistance |
| | 158 | (4) |
| 3.3. Bioenvironmental Malaria Control |
| | 162 | (2) |
| | 164 | (1) |
| | 165 | (4) |
| 8. The Rate of Mutation of Human Genes | | 169 | (6) |
| |
| 9. Disease and Evolution | | 175 | (14) |
| |
| Index | | 189 | |